$BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC)$ Today's market really opened my eyes! BeiGene has quietly reached a historic new high, proving that the spring for innovative drugs has arrived.
From an offering price near 200 to a dip to 98 in the bear market, and now the reversal, it's clear that the industry is on the rise. Last year, Kangfang pulled back after hitting a historical high, still 18 yuan away from its peak, Yasheng is 22 yuan away, and CloudTop is 60 yuan away.
BeiGene in Hong Kong is still 130 yuan away from its historical peak, nearly doubling to reach that point. After a sharp correction, the innovative drug sector in Hong Kong now has more room and greater flexibility for growth.
The future of these leading innovative drug stocks is really something to look forward to!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
